Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Para-n-benzene - sulfoxy-n containing doai – and said benzene...
Patent
1991-01-03
1993-12-28
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Para-n-benzene - sulfoxy-n containing doai, and said benzene...
514155, 514158, 514272, A61K 31505, A61K 3165, A61K 31255
Patent
active
052739708
ABSTRACT:
The antibacterial substance baquiloprim (2,4-diamino-5-[8-dimethylamino-7-methyl-5-quinolylmethyl]pyrimidine) is shown to be active against protozoal infections, e.g. toxoplasmosis. Preferably the baquiloprim is administered together with a sulphonamide.
REFERENCES:
patent: 3969520 (1976-07-01), Garzia
patent: 4587342 (1986-05-01), Daluge et al.
patent: 4761475 (1988-08-01), Daluge et al.
Burchall and Hitchings, "Inhibitor Binding Analysis of Dihydrofolate Reductases from Various Species," Mol. Pharmacol. 1, 126-136 (1965).
Hitchings and Bushby Proc. 5th Int. Cong. Biochem., Section 7, Abstract 7.42.
The Merck Manual, 5th edition, p. 671, 1987.
Coopers Animal Health Limited
Waddell Frederick E.
Weddington K.
LandOfFree
Treatment of protozoal diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of protozoal diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of protozoal diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1542746